Acedapsone

Acedapsone
Clinical data
Trade names	Rodilone; Hansolar
ATC code	none;
Identifiers
	IUPAC name N-[4-(4-acetamidophenyl)sulfonylphenyl]acetamide;
CAS Number	77-46-3 ;
PubChem CID	6477;
ChemSpider	6232 ;
UNII	0GZ72U84TN;
KEGG	D02751 ;
ChEMBL	ChEMBL154166 ;
CompTox Dashboard (EPA)	DTXSID1021295 ;
ECHA InfoCard	100.000.936
Chemical and physical data
Formula	C16H16N2O4S
Molar mass	332.37 g·mol−1
3D model (JSmol)	Interactive image;
Melting point	290 °C (554 °F)
	SMILES CC(=O)NC1=CC=C(C=C1)S(=O)(=O)C2=CC=C(C=C2)NC(=O)C;
	InChI InChI=1S/C16H16N2O4S/c1-11(19)17-13-3-7-15(8-4-13)23(21,22)16-9-5-14(6-10-16)18-12(2)20/h3-10H,1-2H3,(H,17,19)(H,18,20) ; Key:AMTPYFGPPVFBBI-UHFFFAOYSA-N ;
	(what is this?) (verify)

Acedapsone (INN) is an antimicrobial drug, which also has antimalarial activity.

Acedapsone is the INN for diacetyldapsone. It was synthesized and developed in 1937 by Ernest Fourneau and his team in the pharmaceutical chemistry laboratory of Pasteur Institute, and it was marketed as Rodilone by the Rhône-Poulenc company.

It is a long-acting prodrug of dapsone. It is used for treating leprosy.

It crystallises as pale yellow needles from diethyl ether, and as leaflets from dilute ethanol. It is slightly soluble in water.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.